Suleman Khan Zadran

10.1002/advs.202415356 Post-print Neuroblastoma, Humans, Animals, Zebrafish, Gangliosides, Cell Line, Tumor, Bacteriophages, Oncolytic Virotherapy, Photochemotherapy, Photosensitizing Agents, CRISPRa, M13 bacteriophage biotherapeutics, neuroblastoma GD2, photodynamic therapy, zebrafish xenograft yes Zadran, Suleman Khan; Facchinello, Nicola; De Rosa, Piergiuseppe; et al., "Systematic Targeting of GD2-Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector Platform" (2025).

1 Introduction Neuroblastoma (NB) is one of the most common pediatric neuroendocrine tumors originating from neural crest-derived sympathoadrenal precursor cells and accounts for 15% of total pediatric cancer mortalities.[1] NB is a highly heterogeneous disease ranging from asymptomatic malignancy with spontaneous regression to aggressive metastatic disease, culminating in poor clinical outcome.[2] Recent treatments for High-Risk NB rely on synergistic approaches consisting of conventional...

Open AccessArticle by Piergiuseppe De Rosa , Federica Severi , Suleman Khan Zadran , Marco Russo , Sara Aloisi , Alberto Rigamonti , Giovanni Capranico , Giorgio Milazzo *,† and Giovanni Perini *,† Department of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 40126 Bologna, Italy * Authors to whom correspondence should be addressed. † These authors contributed equally to this work. Int. J. Mol. Sci.